vs

Side-by-side financial comparison of ABEONA THERAPEUTICS INC. (ABEO) and NOVARTIS AG (NVS). Click either name above to swap in a different company.

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel gene and cell therapies for life-threatening rare genetic diseases. Its pipeline addresses unmet medical needs, serving patient populations across North America and European markets with limited treatment alternatives.

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABEO
ABEO
NVS
NVS
Q3 25
$0
Q2 25
$400.0K
Net Profit
ABEO
ABEO
NVS
NVS
Q3 25
$-5.2M
Q2 25
$108.8M
Operating Margin
ABEO
ABEO
NVS
NVS
Q3 25
Q2 25
-5698.0%
Net Margin
ABEO
ABEO
NVS
NVS
Q3 25
Q2 25
27208.3%
EPS (diluted)
ABEO
ABEO
NVS
NVS
Q3 25
$-0.10
Q2 25
$1.71

Related Comparisons